Page 228 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation
P. 228
Chapter 8
Supplemental materials
1. Start follow-up
For 7 out of 8 studies date of baseline PET was available, whereas date of diagnosis was available for 6 out of 8 studies. Date of baseline PET was not available for all patients of the NordicUS trial (n=61) and 123 patients of the HOVON84 trial, for those patients, we used date of imaging evaluation.
2. Supplemental tables
226
